Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review
BACKGROUND: Stroke is one of many leading causes of death and disability worldwide. Despite decades of research, treatment for stroke recovery is still inadequate. Recently, mesenchymal stem cell (MSC) therapy is considered as one of the potential treatments for stroke due to their capabilities to r...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Secretariat of The Indonesian Biomedical Journal
2023-12-01
|
| Series: | Indonesian Biomedical Journal |
| Online Access: | https://inabj.org/index.php/ibj/article/view/2460 |
| _version_ | 1797397440034242560 |
|---|---|
| author | Muhammad Agus Aulia Keri Lestari Ahmad Faried Cynthia Retna Sartika Andi Wijaya Achmad Adam Hanna Gunawan Rima Haifa Nabilla Farah Naura Billy Yosua Costantin Pongajow |
| author_facet | Muhammad Agus Aulia Keri Lestari Ahmad Faried Cynthia Retna Sartika Andi Wijaya Achmad Adam Hanna Gunawan Rima Haifa Nabilla Farah Naura Billy Yosua Costantin Pongajow |
| author_sort | Muhammad Agus Aulia |
| collection | DOAJ |
| description | BACKGROUND: Stroke is one of many leading causes of death and disability worldwide. Despite decades of research, treatment for stroke recovery is still inadequate. Recently, mesenchymal stem cell (MSC) therapy is considered as one of the potential treatments for stroke due to their capabilities to repair or regenerate damaged tissues, as well as immunomodulators in inflammatory conditions. Many pre-clinical and clinical trials have shown MSC therapy feasibility, safety, and efficacy in treating stroke. However, evidence regarding the optimal treatment plan and factors that can improve stem cell functional outcomes in treating stroke needs to be further explored. Therefore, a systematic review was conducted.
METHODS: Recent literatures from 2015-2022 regarding stem cell therapies, specifically MSC on ischemic stroke, were collected from two reliable databases: PubMed and PubMed Central. Collected literatures were properly applied to inclusion-exclusion criteria and appraised critically. Keyword strategies on databases were employed, including both medical subject headings (MeSH).
RESULTS: Five literatures from 726 were identified and used for systematic review. All animal model in the literatures were prepared to have middle cerebral artery occlusion. All studies indicated that MSC therapy is a safe and reliable procedure despite the variety of transplantation routes. No report of toxicity, rejection reaction, nor infection on MSC treated groups.
CONCLUSION: Stem cell sources, dosages, and delivery routes could be resourceful for future translational studies to ensure the safety and efficacy of MSC therapy for ischemic stroke.
KEYWORDS: ischemic stroke, mesenchymal stem cells, regenerative medicine, immunomodulator |
| first_indexed | 2024-03-09T01:10:58Z |
| format | Article |
| id | doaj.art-c4f8456618624de98f4080c2e3102a07 |
| institution | Directory Open Access Journal |
| issn | 2085-3297 2355-9179 |
| language | English |
| last_indexed | 2024-03-09T01:10:58Z |
| publishDate | 2023-12-01 |
| publisher | Secretariat of The Indonesian Biomedical Journal |
| record_format | Article |
| series | Indonesian Biomedical Journal |
| spelling | doaj.art-c4f8456618624de98f4080c2e3102a072023-12-11T07:01:07ZengSecretariat of The Indonesian Biomedical JournalIndonesian Biomedical Journal2085-32972355-91792023-12-01156351710.18585/inabj.v15i6.2460543Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic ReviewMuhammad Agus Aulia0Keri Lestari1Ahmad Faried2Cynthia Retna Sartika3Andi Wijaya4Achmad Adam5Hanna Gunawan6Rima Haifa7Nabilla Farah Naura8Billy Yosua Costantin Pongajow9Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung Sumedang KM 21, Jatinangor 45363Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung Sumedang KM 21, Jatinangor 45363Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran – Hasan Sadikin Hospital, Jl. Professor Eyckman No.38, Bandung 40161PT Prodia StemCell Indonesia, Jl. Kramat VII No.11, Jakarta, 10430Prodia Clinical Laboratory, Jl. Supratman No 43, Bandung 40114Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran – Hasan Sadikin Hospital, Jl. Professor Eyckman No.38, Bandung 40161Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Jl. Raya Bandung Sumedang KM 21, Jatinangor 45363PT Prodia StemCell Indonesia, Jl. Kramat VII No.11, Jakarta, 10430PT Prodia StemCell Indonesia, Jl. Kramat VII No.11, Jakarta, 10430PT Prodia StemCell Indonesia, Jl. Kramat VII No.11, Jakarta, 10430BACKGROUND: Stroke is one of many leading causes of death and disability worldwide. Despite decades of research, treatment for stroke recovery is still inadequate. Recently, mesenchymal stem cell (MSC) therapy is considered as one of the potential treatments for stroke due to their capabilities to repair or regenerate damaged tissues, as well as immunomodulators in inflammatory conditions. Many pre-clinical and clinical trials have shown MSC therapy feasibility, safety, and efficacy in treating stroke. However, evidence regarding the optimal treatment plan and factors that can improve stem cell functional outcomes in treating stroke needs to be further explored. Therefore, a systematic review was conducted. METHODS: Recent literatures from 2015-2022 regarding stem cell therapies, specifically MSC on ischemic stroke, were collected from two reliable databases: PubMed and PubMed Central. Collected literatures were properly applied to inclusion-exclusion criteria and appraised critically. Keyword strategies on databases were employed, including both medical subject headings (MeSH). RESULTS: Five literatures from 726 were identified and used for systematic review. All animal model in the literatures were prepared to have middle cerebral artery occlusion. All studies indicated that MSC therapy is a safe and reliable procedure despite the variety of transplantation routes. No report of toxicity, rejection reaction, nor infection on MSC treated groups. CONCLUSION: Stem cell sources, dosages, and delivery routes could be resourceful for future translational studies to ensure the safety and efficacy of MSC therapy for ischemic stroke. KEYWORDS: ischemic stroke, mesenchymal stem cells, regenerative medicine, immunomodulatorhttps://inabj.org/index.php/ibj/article/view/2460 |
| spellingShingle | Muhammad Agus Aulia Keri Lestari Ahmad Faried Cynthia Retna Sartika Andi Wijaya Achmad Adam Hanna Gunawan Rima Haifa Nabilla Farah Naura Billy Yosua Costantin Pongajow Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review Indonesian Biomedical Journal |
| title | Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review |
| title_full | Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review |
| title_fullStr | Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review |
| title_full_unstemmed | Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review |
| title_short | Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review |
| title_sort | mesenchymal stem cell therapy for ischemic stroke in animal model a systematic review |
| url | https://inabj.org/index.php/ibj/article/view/2460 |
| work_keys_str_mv | AT muhammadagusaulia mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT kerilestari mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT ahmadfaried mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT cynthiaretnasartika mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT andiwijaya mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT achmadadam mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT hannagunawan mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT rimahaifa mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT nabillafarahnaura mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview AT billyyosuacostantinpongajow mesenchymalstemcelltherapyforischemicstrokeinanimalmodelasystematicreview |